BlackRock »

Ptc Therapeutics I shares owned by BlackRock

Quarter-by-quarter ownership of Ptc Therapeutics I (PTCT) shares owned by BlackRock from 13F filings

Historical chart of BlackRock investment in Ptc Therapeutics I

Tip: Access up to 7 years of quarterly data

All positions including Ptc Therapeutics I held by BlackRock consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ptc Therapeutics I by BlackRock

Quarter filed Position value Share count Share price at filing
2024-09-30 $296M 8.0M 37.10

More positions owned by BlackRock

Apple (AAPL)
Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Alphabet Cap Stk Cl C (GOOG)
Eli Lilly & Co. (LLY)
Tesla Motors (TSLA)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
UnitedHealth (UNH)
JPMorgan Chase & Co. (JPM)
Ishares Tr Core S&p500 Etf (IVV)
Visa Com Cl A (V)

View all positions for BlackRock

Top funds holding Ptc Therapeutics I

Vanguard Group
BlackRock
BlackRock
Armistice Capital
Cowen And Company
Henderson Group
State Street Corporation
Geode Capital Management
Morgan Stanley
Jacobs Levy Equity Management
D. E. Shaw & Co
Franklin Resources
Blackstone Group
Goldman Sachs Group
Charles Schwab Investment Management

View all funds holding Ptc Therapeutics I